Finance

Lists
Why is NAUT down 2,52%?
Dive Deeper
NAUT:NASDAQ
Nautilus Biotechnology Inc
2,32 $
-2,52%
(-0,060) 1D
13 қар., 16:00:00 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NAUT...
Open
2,39 $
High
2,40 $
Low
2,20 $
Mkt. cap
295,50 млн
Avg. vol.
10,18 млн
Volume
1,88 млн
52-wk high
4,31 $
52-wk low
0,84 $
EPS
-0,46 $
Beta
0,66
Shares outstanding
127,37 млн
No. of employees
128
Open
2,39 $
High
2,40 $
Low
2,20 $
Mkt. cap
295,50 млн
Avg. vol.
10,18 млн
Volume
1,88 млн
52-wk high
4,31 $
52-wk low
0,84 $
EPS
-0,46 $
Beta
0,66
Shares outstanding
127,37 млн
No. of employees
128
News stories
From web sources and news partners
About Nautilus Biotechnology Inc
CEO-
Employees128
Founded2016
HeadquartersСиэтл, Вашингтон, Америка Құрама Штаттары
SectorHealth Care
Industry-
Analyst ratings
Based on 3 analysts giving stock ratings to NAUT in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for NAUT in the last 3 months.
Highest
Current 2,32 $
4,00 $ (+72,41%)
Average
4,00 $ (+72,41%)
Lowest
4,00 $ (+72,41%)
Analyst
Recommendation
Action
Price target
Projected
Date
Max Masucci
Roth MKM
Buy
Maintained
4,00 $
+72,4%
10/28/2026
Unknown Analyst
Guggenheim
Buy
Reiterated
4,00 $
+72,4%
10/27/2026
Unknown Analyst
Leerink Partners
Buy
Initiated
4,00 $
+72,4%
09/09/2026
Subbu Nambi
Guggenheim
Buy
Reiterated
4,00 $
+72,4%
07/28/2026
Daniel Brennan
TD Cowen
Buy
Maintained
-
-
04/28/2026
Last report
2026 ж. 27 қаз.
Fiscal period
Q3 2026
-0,12 $ / -0,16 $
+25,00%beat
Revenue / Est. (USD)
234,00 м. / 206,25 м.
+13,45%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
2026 ж. қыр.
Revenue
-
-
190,00 м.
234,00 м.
Cost of goods sold
-
-
15,00 мың
24,00 мың
Cost of revenue
-
-
15,00 мың
24,00 мың
Research and development expenses
9,58 млн
9,71 млн
9,61 млн
10,18 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5,85 млн
6,42 млн
6,32 млн
6,77 млн
Operating expense
15,42 млн
16,12 млн
15,94 млн
16,95 млн
Total operating expenses
15,42 млн
16,12 млн
15,95 млн
16,97 млн
Operating income
-15,42 млн
-16,12 млн
-15,76 млн
-16,74 млн
Other non operating income
-145,00 м.
-15,00 мың
-13,00 мың
-72,00 мың
EBT including unusual items
-13,78 млн
-14,70 млн
-14,47 млн
-15,64 млн
EBT excluding unusual items
-13,92 млн
-14,70 млн
-14,47 млн
-15,64 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-13,78 млн
-14,70 млн
-14,47 млн
-15,64 млн
Net profit margin
-
-
-7 615,26%
-6 682,05%
Earnings per share
-
-
-
-
Interest and investment income
1,65 млн
1,44 млн
1,31 млн
1,17 млн
Interest expense
-
-
-
-
Net interest expenses
1,65 млн
1,44 млн
1,31 млн
1,17 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-15,02 млн
-15,79 млн
-15,49 млн
-16,46 млн
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google қолданбалары